Tang Jialin, Li Zhongxia, Wu Qiong, Irfan Muhammad, Li Weili, Liu Xiangyu
Guangdong Key Laboratory of Genome Instability and Human Disease Prevention, Department of Biochemistry and Molecular Biology, Shenzhen University School of Medicine, Shenzhen, China.
Department of Hematology, The Second People's Hospital of Shenzhen, Shenzhen, China.
Front Immunol. 2022 Mar 2;13:852453. doi: 10.3389/fimmu.2022.852453. eCollection 2022.
Non-homologous end joining (cNHEJ) is a major pathway to repair double-strand breaks (DSBs) in DNA. Several core cNHEJ are involved in the progress of the repair such as KU70 and 80, DNA-dependent protein kinase catalytic subunit (DNA-PKcs), Artemis, X-ray repair cross-complementing protein 4 (XRCC4), DNA ligase IV, and XRCC4-like factor (XLF). Recent studies have added a number of new proteins during cNHEJ. One of the newly identified proteins is Paralogue of XRCC4 and XLF (PAXX), which acts as a scaffold that is required to stabilize the KU70/80 heterodimer at DSBs sites and promotes the assembly and/or stability of the cNHEJ machinery. PAXX plays an essential role in lymphocyte development in XLF-deficient background, while XLF/PAXX double-deficient mouse embryo died before birth. Emerging evidence also shows a connection between the expression levels of PAXX and cancer development in human patients, indicating a prognosis role of the protein. This review will summarize and discuss the function of PAXX in DSBs repair and its potential role in cancer development.
非同源末端连接(cNHEJ)是修复DNA双链断裂(DSB)的主要途径。几种核心的cNHEJ蛋白参与了修复过程,如KU70和KU80、DNA依赖蛋白激酶催化亚基(DNA-PKcs)、Artemis、X射线修复交叉互补蛋白4(XRCC4)、DNA连接酶IV以及XRCC4样因子(XLF)。最近的研究发现了一些在cNHEJ过程中发挥作用的新蛋白。其中一个新发现的蛋白是XRCC4和XLF的旁系同源物(PAXX),它作为一种支架蛋白,在DSB位点稳定KU70/80异二聚体,并促进cNHEJ机制的组装和/或稳定性。在XLF缺陷背景下,PAXX在淋巴细胞发育中起重要作用,而XLF/PAXX双缺陷的小鼠胚胎在出生前死亡。新出现的证据还表明,PAXX的表达水平与人类患者的癌症发展有关,提示该蛋白具有预后作用。本综述将总结并讨论PAXX在DSB修复中的功能及其在癌症发展中的潜在作用。